140 related articles for article (PubMed ID: 38399348)
1. Design and Characterization of Ocular Inserts Loaded with Dexamethasone for the Treatment of Inflammatory Ophthalmic Disease.
Guadarrama-Escobar OR; Valdés-Alvarez CA; Constantino-Gonzalez KS; Serrano-Castañeda P; Peña-Juárez MC; Morales-Florido MI; Salgado-Machuca M; Rodríguez-Pérez B; Rodriguez-Cruz IM; Vargas-Estrada D; Mercado-Márquez C; Vázquez-Durán A; Méndez-Albores A; Anguíano-Almazán E; Escobar-Chavez JJ
Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399348
[TBL] [Abstract][Full Text] [Related]
2. Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E₂-induced ocular inflammation.
Mathurm M; Gilhotra RM
Drug Deliv; 2011 Jan; 18(1):54-64. PubMed ID: 20718601
[TBL] [Abstract][Full Text] [Related]
3. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
[TBL] [Abstract][Full Text] [Related]
4. Piroxicam bioadhesive ocular inserts: physicochemical characterization and evaluation in prostaglandin-induced inflammation.
Gilhotra RM; Gilhotra N; Mishra DN
Curr Eye Res; 2009 Dec; 34(12):1065-73. PubMed ID: 19958126
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
Aburahma MH; Mahmoud AA
AAPS PharmSciTech; 2011 Dec; 12(4):1335-47. PubMed ID: 21979886
[TBL] [Abstract][Full Text] [Related]
6. Design and Evaluation of Ocular Controlled Delivery System for Diclofenac Sodium.
Jafariazar Z; Jamalinia N; Ghorbani-Bidkorbeh F; Mortazavi SA
Iran J Pharm Res; 2015; 14(Suppl):23-31. PubMed ID: 26185502
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma.
Tighsazzadeh M; Mitchell JC; Boateng JS
Int J Pharm; 2019 Jul; 566():111-125. PubMed ID: 31129346
[TBL] [Abstract][Full Text] [Related]
8. Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery.
Yousry C; Elkheshen SA; El-Laithy HM; Essam T; Fahmy RH
Eur J Pharm Sci; 2017 Mar; 100():142-154. PubMed ID: 28089661
[TBL] [Abstract][Full Text] [Related]
9. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
Nanomedicine; 2010 Apr; 6(2):324-33. PubMed ID: 19857606
[TBL] [Abstract][Full Text] [Related]
10. Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation.
Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Rodrigues LB; Bravo R; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SO; Cronemberger S; Ferreira AJ; Faraco AA
PLoS One; 2014; 9(4):e95461. PubMed ID: 24788066
[TBL] [Abstract][Full Text] [Related]
11. Supramolecular nanofibers of dexamethasone derivatives to form hydrogel for topical ocular drug delivery.
Zhang Z; Yu J; Zhou Y; Zhang R; Song Q; Lei L; Li X
Colloids Surf B Biointerfaces; 2018 Apr; 164():436-443. PubMed ID: 29438842
[TBL] [Abstract][Full Text] [Related]
12. Formulation and Evaluation of Atorvastatin Calcium-Poly-ε-Caprolactone Nanoparticles Loaded Ocular Inserts for Sustained Release and Antiinflammatory Efficacy.
Girgis GNS
Curr Pharm Biotechnol; 2020; 21(15):1688-1698. PubMed ID: 32427080
[TBL] [Abstract][Full Text] [Related]
13. Development and optimization of hot-melt extruded moxifloxacin hydrochloride inserts, for ocular applications, using the design of experiments.
Thakkar R; Komanduri N; Dudhipala N; Tripathi S; Repka MA; Majumdar S
Int J Pharm; 2021 Jun; 603():120676. PubMed ID: 33961956
[TBL] [Abstract][Full Text] [Related]
14. Polymeric Inserts Containing Eudragit
Taghe S; Mirzaeei S; Alany RG; Nokhodchi A
Biomedicines; 2020 Oct; 8(11):. PubMed ID: 33142768
[TBL] [Abstract][Full Text] [Related]
15. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
[TBL] [Abstract][Full Text] [Related]
16. Microfibrillar polymeric ocular inserts for triamcinolone acetonide delivery.
Di Prima G; Licciardi M; Carfì Pavia F; Lo Monte AI; Cavallaro G; Giammona G
Int J Pharm; 2019 Aug; 567():118459. PubMed ID: 31247275
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin novel drug delivery system for ocular application.
Gilhotra RM; Nagpal K; Mishra DN
Int J Pharm Investig; 2011 Jan; 1(1):22-8. PubMed ID: 23071916
[TBL] [Abstract][Full Text] [Related]
18. Design, formulation, and evaluation of novel sustain release bioadhesive in-situ gelling ocular inserts of ketorolac tromethamine.
Jethava JK; Jethava GK
Int J Pharm Investig; 2014 Oct; 4(4):226-32. PubMed ID: 25426444
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone-loaded keratin films for ocular surface reconstruction.
Schwab R; Reichl S
J Mater Sci Mater Med; 2022 Mar; 33(3):29. PubMed ID: 35244790
[TBL] [Abstract][Full Text] [Related]
20. Physiologically Based Pharmacokinetic Model to Support Ophthalmic Suspension Product Development.
Le Merdy M; Tan ML; Babiskin A; Zhao L
AAPS J; 2020 Jan; 22(2):26. PubMed ID: 31907674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
